In the current study, although the number of cases analyzed was small, CREB3L1 in PLT mRNA accurately discriminated PV from NNE, demonstrating the high potential of CREB3L1 as a reliable biomarker for the diagnosis of MPN. The gene discussed is CREB3L1; the disease is myeloproliferative disorder.